Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
T-Guard (ricin toxin A conjugated mAB) is designed to reset the body's immune system in life-threatening T cell‒mediated conditions, potentially including prevention of transplant-related rejection, treatment of acute solid-organ rejection, and severe autoimmune disease.
Lead Product(s): Ricin Toxin A Conjugated Monoclonal Antibodies
Therapeutic Area: Immunology Product Name: T-Guard
Highest Development Status: Phase IIIProduct Type: Large molecule
Recipient: Veloxis Pharmaceuticals
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 28, 2022
Details:
T-Guard (ricin toxin A conjugated mAB) is designed to safely and swiftly reset the body’s immune system in life-threatening T cell‒mediated conditions, including transplant-related rejection, acute solid-organ rejection, and severe autoimmune disease.
Lead Product(s): Ricin Toxin A Conjugated Monoclonal Antibodies
Therapeutic Area: Immunology Product Name: T-Guard
Highest Development Status: Phase IIIProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 27, 2022